Literature DB >> 30918169

Meningoencephalitis Caused by a Campylobacter fetus in a Patient with Chronic Alcoholism.

Sho Tanabe1, Satoshi Kutsuna1, Motoyuki Tsuboi1, Nozomi Takeshita1, Kayoko Hayakawa1, Norio Ohmagari1.   

Abstract

We herein report a case of Campylobacter fetus meningoencephalitis in a patient with chronic alcoholism. C. fetus is a rare cause of meningitis. The patient presented with hallucinations and monology, and alcohol withdrawal was initially suspected. After he was unsuccessfully treated for alcohol withdrawal delirium, we diagnosed C. fetus meningoencephalitis. Ampicillin monotherapy gradually improved his clinical status. A previous report stated that C. fetus infection is associated with chronic alcoholism. In patients with chronic alcoholism and disturbed consciousness, an atypical bacterial central nervous system infection, such as C. fetus meningoencephalitis, should be considered.

Entities:  

Keywords:  Campylobacter fetus; ampicillin; chronic alcoholism; meningoencephalitis

Mesh:

Substances:

Year:  2019        PMID: 30918169      PMCID: PMC6709320          DOI: 10.2169/internalmedicine.1486-18

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


Introduction

Meningoencephalitis can cause disturbed consciousness, and rapid identification with prompt appropriate therapy is important for achieving optimal outcomes. However, this disease may be misdiagnosed because disturbed consciousness makes it difficult to obtain enough information from the patient. We herein report a case of Campylobacter fetus meningoencephalitis that was treated as alcohol withdrawal because of the patient's history of habitual drinking.

Case Report

A 56-year-old man with a history of chronic alcoholism experienced disturbed consciousness over several days and was subsequently brought to the Psychiatry Department at our hospital from a nearby mental hospital. A psychiatric evaluation revealed that the patient presented with hallucinations and monology. Based on the patient's history of chronic alcoholism, he was treated for alcohol-withdrawal-associated delirium. Upon admission, he also exhibited a fever and decubitus, which was treated with cefazolin (1 g every 8 hours) for presumed infection. On day 6 of admission, positive results for C. fetus were obtained from his blood culture. Psychiatrists contacted our Department of Infectious Diseases and we initiated a careful evaluation of the patient. When we contacted the patient, he still had hallucination and monology. He did not complain of headache or nausea and did not have a history of eating raw meat before admission. A physical examination revealed normal findings of his respiratory system, cardiovascular system, and abdomen. Although he did not have a headache, we detected mild neck rigidity, possibly indicating meningitis. Laboratory tests also revealed a slightly elevated white blood cell count (9,910/μL) and C-reactive protein level (0.9 mg/dL). A lumbar puncture was performed, and the patient's cerebrospinal fluid (CSF) was clear and colorless. The initial pressure was 100 mmH2O. The CSF cell count was 142/μL (neutrophils: 56/μL, lymphocytes: 86/μL), glucose level was 58 mg/dL (plasma glucose level 99 mg/dL, CSF to serum glucose ratio 0.57), and protein level was 94 mg/dL; no micro-organisms were observed on Gram staining of CSF. Contrast-enhanced magnetic resonance imaging (MRI) revealed multiple areas of inflammation in the cortex, meninx, and dura mater, which indicated meningoencephalitis. Considering the results of the blood culture and contrast-enhanced MRI, we started ampicillin (3 g every 6 hours) for suspected C. fetus meningoencephalitis. On day 16, we identified growth of C. fetus in the culture of a CSF specimen, and it took 10 days to receive the results of the culture after we obtained CSF. Our lab measured the minimum inhibitory concentration (MIC) by the E test for ampicillin (4 μg/mL). The patient's condition gradually improved after initiating the ampicillin treatment, and we also detected improvements in his disturbed consciousness. After four weeks of intravenous ampicillin treatment, we observed that the patient had fully recovered his disturbed consciousness, and he was discharged. At three weeks post-discharge, MRI confirmed that his brain inflammation had improved (Figure).
Figure.

Contrast-enhanced magnetic resonance image of the patient’s brain. (A) Fluid-attenuated inversion recovery images from before treatment revealed acute brain inflammation. (B) Images obtained at the three-week follow-up after discharge revealed improvement in the inflammation.

Contrast-enhanced magnetic resonance image of the patient’s brain. (A) Fluid-attenuated inversion recovery images from before treatment revealed acute brain inflammation. (B) Images obtained at the three-week follow-up after discharge revealed improvement in the inflammation.

Discussion

In the present case, the patient did not complain of typical meningitis symptoms, such as headache or nausea. Previous reports have shown that few C. fetus meningoencephalitis cases present with a classic meningitis triad (1). MRI was helpful in the diagnosis of C. fetus meningoencephalitis. The MRI finding implied central nervous system infection or limbic encephalitis and we could rule out other neurological diseases such as Wernicke's encephalopathy. Although C. fetus infections are most frequently observed among patients with immunocompromised status, such as those with diabetes, malignancy, corticosteroid therapy, or hepatic failure (2), we speculate that chronic alcoholism was strongly related to this case. In 1998, Dronda et al. reviewed the literature regarding C. fetus meningitis and reported that 4 of 8 cases (50%) involved chronic alcoholism (3). In addition, van Samkar et al. reviewed the literature regarding C. fetus meningitis and found that 9 of 22 patients (40%) with C. fetus meningitis between 1960 and 2013 had chronic alcoholism (1). In total, we identified 24 previously published cases that also showed a relationship between alcohol and C. fetus meningitis (Table) (1,3-21). These findings imply that C. fetus meningoencephalitis may also be related to chronic alcoholism.
Table.

Summary of the Clinical Data of Patients with Campylobacter Fetus Meningoencephalitis.

Case no. (reference)SexAgeUnderlying condition(s)WBC in CSFCSF glucoseCSF proteinNeck stiffnessHeadacheConfusionImagingTreatmentOutcome
Present caseM56Chronic alcoholism142/μL58 mg/dL94 mg/dL+-+contrast MRIABPCCured
1 (1)F23NA308/μL30.6 mg/dL90 mg/dL+--NAAMPC, CTRXCured
2 (1)M52NA243/μL18 mg/dL176 mg/dL+--NAAMPC, CTRXCured
3 (6)M38Chronic alcoholism2,048/μL48.6 mg/dL100 mg/dL+--NAABPC, GMCured
4 (7)M68Metastatic adenocarcinoma of rectumNANANANANANANAEMDied
5 (7)M65Alcoholic cirrhosisNANANANANANANACEZ, TOB, AMPC, GMCured
6 (8)M47Diabetes mellitus48/μL104.4 mg/dL81 mg/dLNANANANACP, EMCured
7 (9)F39Chronic alcoholismNA5.4 mg/dL131 mg/dLNANANANAAMPC/CVACured
8 (9)M36Chronic alcoholismNA30 mg/dL95 mg/dLNANANANAABPC, THPCured
9 (10)M83Alcoholic cirrhosis577/μL91.8 mg/dL60 mg/dLNANANANACPFX, CTRXDied
10 (3)M47Chronic alcoholism300/μL57.6 mg/dL85 mg/dLNANANANAOFLX, GMCured
11 (5)M71Diabetes mellitus11,100/μL95.4 mg/dL508 mg/dL+-NANAABPC, GM, IPM, CTX, CPFXCured
12 (11)M47Chronic alcoholism2,128/μL240 mg/dL152 mg/dL+-NANAPEN, TETCured
13 (12)M55Chronic lymphocytic leukemia240/μLNANA+-NANAPEN, TETCured
14 (13)F48Rheumatic fever1,399/μLNANA+-NANAPEN, CPCured
15 (14)M50Diabetes mellitus3,436/μL20 mg/dL96 mg/dL-+NANAPEN, ABPC, CPCured
16 (15)F69Diabetes mellitus1,230/μLNANA--NANAPEN, CP, SFZDied
17 (16)M40NA8,464/μL50 mg/dL120 mg/dL+--NAABPC, PEN, STR, EMCured
18 (17)M50NA36/μL70 mg/dL73 mg/dL-+-NAABPC, CPCured
19 (9)M36Chronic alcoholism156/μL22 mg/dL95 mg/dL---NAAMPCCured
20 (18)M55Alcoholic hepatitis400/μL106 mg/dL83 mg/dL+--NAABPCCured
21 (19)M51NANANANA---NAABPC, MFLXCured
22 (20)M40Crohn’s disease344/μL68 mg/dL33 mg/dL-+-NANACured
23 (21)M28Epilepsy170/μLNANA+--NAEMCured
24 (4)M75Diabetes mellitus1,430/μL268 mg/dL114 mg/dL--+NACTX, CPFX, AZMCured

ABPC: ampicillin, CTRX: ceftriaxone, GM: gentamicin, EM: erythromycin, CEZ: cefazolin, TOB: tobramycin, AMPC/CVA: amoxicillin/clavulanate, CP: chloramphenicol, OFLX: ofloxacin, IPM: imipenem, CPFX: ciprofloxacin, PEN: penicillin, TET: tetracycline, SFZ: sulfadiazine, STR: streptomycin, MFLX: moxifloxacin, AZM: azithromycin

Summary of the Clinical Data of Patients with Campylobacter Fetus Meningoencephalitis. ABPC: ampicillin, CTRX: ceftriaxone, GM: gentamicin, EM: erythromycin, CEZ: cefazolin, TOB: tobramycin, AMPC/CVA: amoxicillin/clavulanate, CP: chloramphenicol, OFLX: ofloxacin, IPM: imipenem, CPFX: ciprofloxacin, PEN: penicillin, TET: tetracycline, SFZ: sulfadiazine, STR: streptomycin, MFLX: moxifloxacin, AZM: azithromycin No treatment protocol for C. fetus meningoencephalitis has yet been established. While the present case was successfully treated with ampicillin monotherapy, as shown in Table, most previously documented C. fetus meningitis cases were treated with multiple or broad-spectrum antibiotics. However, there is no clear evidence that C. fetus meningitis should be treated with multiple antibiotics, as two other cases were successfully treated by ampicillin or amoxicillin monotherapy (4). One other report recommended using imipenem for C. fetus central nervous system infections or patients with a severe status (5). However, this treatment has some problems. First, the use of broad-spectrum antibiotics such as imipenem must be limited in order to prevent the growth of organisms resistant to antibiotics. Ohmagari et al. showed that the use of carbapenems for seven days was a risk factor for infections with multidrug-resistant Pseudomonas aeruginosa (22). Second, imipenem carries an additional risk. Van De Beek et al. recommended avoiding imipenem for meningitis treatment because it could lower the seizure threshold (23). In the present case, once positive results for C. fetus were obtained from the blood culture, we suspected C. fetus meningoencephalitis and started ampicillin monotherapy. At this time, other bacteria were not suspected to be the cause of meningitis; therefore, we did not select empiric therapy and did not use imipenem, which is not recommended for bacterial meningitis. When patients with chronic alcoholism present with central nervous system symptoms, we tend to diagnose alcohol-related diseases, such as alcohol withdrawal or Wernicke's encephalitis. However, if the patient's symptoms do not improve after appropriate treatment for alcohol withdrawal, we should consider the possibility of central nervous system infection and expand the examinations. As seen in the present case, results of MRI and lumbar puncture helped us make a correct diagnosis. In conclusion, we encountered a case of C. fetus meningoencephalitis with chronic alcoholism successfully treated by ampicillin monotherapy.

The authors state that they have no Conflict of Interest (COI).
  23 in total

1.  PROTRACTED BACTEREMIA AND MENINGITIS DUE TO VIBRIO FETUS.

Authors:  H S COLLINS; A BLEVINS; E BENTER
Journal:  Arch Intern Med       Date:  1964-03

2.  Campylobacter fetus subspecies fetus meningitis with chronic alcoholism and diabetes mellitus.

Authors:  H Kato; H Wakasugi; T Mukuta; M Furukawa; M Yokota; Y Yamada; A Funakoshi; M Abe
Journal:  Jpn J Med       Date:  1990 Sep-Oct

3.  [Apropos of 3 cases of human vibriosis (Vibrio fetus), including 1 case of meningitis].

Authors:  L A ROBIN; G DUPREY; J F JOUANNOT; P PARIS; H MAGARD; J MIGNARD; P BERTEAU
Journal:  Presse Med       Date:  1962-02-10       Impact factor: 1.228

4.  Campylobacter fetus meningitis in a patient with Crohn's disease.

Authors:  Yasushi Umehara; Masatoshi Kudo; Masanori Kawasaki
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

Review 5.  Advances in treatment of bacterial meningitis.

Authors:  Diederik van de Beek; Matthijs C Brouwer; Guy E Thwaites; Allan R Tunkel
Journal:  Lancet       Date:  2012-11-10       Impact factor: 79.321

6.  Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer.

Authors:  Norio Ohmagari; Hend Hanna; Linda Graviss; Brenda Hackett; Cheryl Perego; Virginia Gonzalez; Tanya Dvorak; Holly Hogan; Ray Hachem; Kenneth Rolston; Issam Raad
Journal:  Cancer       Date:  2005-07-01       Impact factor: 6.860

7.  Campylobacter fetus bacteremia in a young healthy adult transmitted by khat chewing.

Authors:  Carlos Martínez-Balzano; Patrick J Kohlitz; Preeti Chaudhary; Housam Hegazy
Journal:  J Infect       Date:  2011-11-23       Impact factor: 6.072

8.  Meningitis and endocarditis caused by Campylobacter fetus after raw-liver ingestion.

Authors:  Florence Suy; Damien Le Dû; Anne-Laure Roux; Mouna Hanachi; Aurélien Dinh; Anne-Claude Crémieux
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

9.  [Case of bilateral subdural empyema complicating Campylobacter fetus subspecies fetus meningitis].

Authors:  Seisaku Kanayama; Kenji Ohnishi; Tadayoshi Yamaura; Mituya Katayama; Jun Makino; Nobuhiko Takemura; Yuichi Hamabe
Journal:  Brain Nerve       Date:  2008-06

10.  Campylobacter fetus meningitis in a diabetic adult cured by imipenem.

Authors:  J Herve; N Aissa; P Legrand; M Sorkine; M J Calmette; A Santin; E Roupie; B Renaud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-20       Impact factor: 3.267

View more
  2 in total

1.  Initial Narrow- or Broad-spectrum Treatment for Meningoencephalitis.

Authors:  Takahiko Fukuchi; Hitoshi Sugawara
Journal:  Intern Med       Date:  2019-09-18       Impact factor: 1.271

2.  Campylobacter fetus thyroid gland abscess in a young immunocompetent woman.

Authors:  Nancy K El Beayni; George F Araj; Sarah Beydoun; Maria Kozah; Zuhayr Tabbarah
Journal:  IDCases       Date:  2019-12-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.